Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 46

  1. Cat.No. Product Name Information/Activity
  2. BCC6582 (R)-AMPA 83654-13-1 (R)-AMPA chemical structure
  3. BCC6560 (RS)-AMPA 74341-63-2 (RS)-AMPA chemical structure
  4. BCC6583 (S)-AMPA 83643-88-3 (S)-AMPA chemical structure
  5. BCC7147 Cl-HIBO 909400-43-7 Cl-HIBO chemical structure
  6. BCC7106 (S)-CPW 399 389888-02-2 (S)-CPW 399 chemical structure
  7. BCC7789 NPEC-caged-(S)-AMPA 1257323-84-4 NPEC-caged-(S)-AMPA chemical structure
  8. BCC6568 L-Quisqualic acid 52809-07-1 L-Quisqualic acid chemical structure
  9. BCC6931 CFM-2 CFM-2 is a selective non-competitive AMPAR antagonist. CFM-2 chemical structure
  10. BCC6569 CNQX CNQX (FG9065) is a potent AMPA/kainate receptor antagonist. CNQX chemical structure
  11. BCC6908 CNQX disodium salt 479347-85-8 CNQX disodium salt chemical structure

Items 451 to 460 of 709 total